4893 Noile-Immune Biotech
- 210
- -9-4.11%
Noile-Immune Biotech News
Noile-Immune Biotech: Notice regarding a business alliance with Takara Bio Co., Ltd. for the development of NIB103
Noile-Immune Biotech: Announcements of individual stocks regarding the re-prioritization of our in-house drug development pipeline and changes in the use of funds raised at the time of listing.
Noile-Immune Biotech: Regarding the return of NIB102 and NIB103 to Takeda Pharmaceutical.
Noile-Immune Biotech: Matters relating to business plans and growth potential
Noile-Immune Biotech: Independent Officer Notification Form
Noile-Immune Biotech: [Delayed]Supplemental Comments on the Termination of the License Agreements for NIB102 and NIB103
Noile-Immune Biotech: Announcement on the Termination of License Agreement for NIB102 and NIB103
Noile-Immune Biotech: Additional comments on the cancellation of the NIB102 and NIB103 license agreements
Noile-Immune Biotech: Notice Concerning Cancellation of NIB102 and NIB103 License Agreements
Noile-Immune Biotech: Achievement of milestones related to the license agreement with Chugai Pharmaceutical
Noile-Immune Biotech: About the partnership between Sysmex and Neulimune Biotech on technology to optimize the function of CAR-T cells
Noile-Immune Biotech: Articles of Incorporation 2022/11/21
Noile-Immune Biotech: Independent Officer Notification Form
Noile-Immune Biotech: Matters relating to business plans and growth potential
Noile-Immune Biotech: Notice regarding changes in other affiliated companies
Noile-Immune Biotech: Notice of our financial results information etc. associated with listing on the Tokyo Stock Exchange Growth Market
Noile-Immune Biotech: Confirmation of the appropriateness of securities reports, etc. for listing applications
Noile-Immune Biotech: Quarterly Report for Listing Applications (First quarter)
Noile-Immune Biotech: Securities reports for listing applications
Analysis
Price Target
No Data
No Data